Administration of Nicotinamide Mononucleotide Mitigates the HIV Nef-Induced Metabolic and Pathological Changes in the Heart
Cells · 01.03.2026 · 15 (5) · 444
DOI: 10.3390/cells15050444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 01.03.2026. Verfasst von Olena Kondrachuk und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolic and Cardiovascular Sciences, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando…. Hauptthemen laut MEDLINE: nef Gene Products, Human Immunodeficiency Virus, Myocardium, Heart. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, LIFE at UCF Gerontology, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Due to the application of antiretroviral therapy, HIV has become a manageable chronic disease, and people living with HIV/AIDS (PLWHA) experience several comorbidities, including cardiovascular disease. Although antiretroviral therapy suppresses the viral load to an undetectable level, HIV proteins can still be detected in the circulation and in different organs. In our previous study, we found that the expression of the Nef protein causes cardiac dysfunction and heart failure in a transgenic mouse model. We also observed inhibition of autophagy along with the upregulation of the senescence marker Bcl2. To further understand the metabolic changes related to Nef in cardiac tissue, we examined nicotinamide adenine dinucleotide (NAD) metabolism in the heart. Our metabolic study with cardiac tissue revealed that Nef expression decreases NAD+ levels in the heart. Additionally, we explored whether replenishing cellular NAD+ could be a potential therapeutic target for HIV-associated cardiovascular disease. Interestingly, our study found that NMN treatment can improve cellular autophagy, decrease the senescence marker Bcl2, and reduce fibrosis in the heart. Overall, our study suggests that NMN could serve as a promising therapeutic molecule for the treatment of HIV-associated cardiovascular comorbidities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Metabolic and Cardiovascular Sciences, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.
- Division of Pathology, Tulane National Primate Research Center, Covington, LA 70433, USA.
ORCID-Profile: Sarah Nguyen, Manish Kumar Gupta
Förderung
- NIH HHS
- LIFE at UCF Gerontology
- National Heart Lung and Blood Institute
- National Heart, Lung, and Blood Institute
- LIFE Gerontology Applied Research Grant from UCF
Zitieren
APA
Kondrachuk, O., Nakhungu, E., Ogundipe, G., Tailor, N., Ciccone, P., Hong, K., Gadiraju, A., Kimura, Y., Zi, A., Yusuf, S., Alkousa, A., Nguyen, S., Rajkumar, R., Do, J., Rappaport, J., & Gupta, M. K. (2026). Administration of Nicotinamide Mononucleotide Mitigates the HIV Nef-Induced Metabolic and Pathological Changes in the Heart. Cells, 15(5), 444. https://doi.org/10.3390/cells15050444
Vancouver
Kondrachuk O, Nakhungu E, Ogundipe G, Tailor N, Ciccone P, Hong K, et al. Administration of Nicotinamide Mononucleotide Mitigates the HIV Nef-Induced Metabolic and Pathological Changes in the Heart. Cells. 2026;15(5):444. doi:10.3390/cells15050444
BibTeX
@article{Kondrachuk2026,
author = {Kondrachuk, Olena and Nakhungu, Esther and Ogundipe, Gbenga and Tailor, Nishit and Ciccone, Pierce and Hong, Kim and Gadiraju, Anvita and Kimura, Yuka and Zi, Artemis and Yusuf, Sumaya and Alkousa, Aya and Nguyen, Sarah and Rajkumar, Rithvik and Do, Jaycee and Rappaport, Jay and Gupta, Manish Kumar},
title = {Administration of Nicotinamide Mononucleotide Mitigates the HIV Nef-Induced Metabolic and Pathological Changes in the Heart},
journal = {Cells},
year = {2026},
volume = {15},
number = {5},
pages = {444},
doi = {10.3390/cells15050444}
}
EUVIMED